Articles On Adherium (ASX:ADR)

ASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitcoin hits US$93k before retreating   Aussie shares climbed higher on Thursday, powered by a rally in tech companies and the big banks. At the...

ASX 200 drops as gold, iron ore and energy stocks struggle Paladin shares plunge after cutting uranium output forecast Australian business confidence hits two-year high amid easing inflation   The ASX 200 index slipped by 0.13% on Tuesday...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Aussie shares slip as RBA holds rates steady MinRes rebounds, Domino’s Don Meij quits Investors rethink Trump comeback as Harris leads in Iowa   Aussie shares slipped into the red on Tuesday, falling 0.4% as sentiment remained subdued aft...

  ASX 200 hits record highs fuelled by Wall Street rally Tech and iron ore stocks lead gains Tyro sinks after government proposes new rules on debit surcharge   The ASX 200 index hit record highs on Tuesday after rising by 0.9%, eclipsin...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

ANDHealth says the Covid-19 pandemic triggered far-reaching changes to Australia’s health system and how we manage respiratory illnesses Lumos Diagnostics has developed FebriDx to helps doctors quickly differentiate a viral from bacterial...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

For biotech investors, the news of an approval by the US FDA is a genuinely exciting milestone. The FDA is the ultimate gatekeeper for the US pharmaceutical market, which is by far the world’s largest. Approval from the FDA not only validat...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Australian respiratory eHealth company Adherium (ASX:ADR) has announced that AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial.

ASX in broad rebound; Cettire, Neuren, and Lendlease lead surge Positive sentiment follows Wall Street strength DY6 Metals up 300pc on  Rare Earths find at the Tundulu project in Malawi   Aussie shares rebounded pretty much across the boa...

ASX drops over 1pc as tech, retail, banks fall; energy resists Bond yields surge, impacting goldies Ethereum ETFs approved, await filings   Energy was the only sector showing some sort of resistance on Friday as the ASX was engulfed in a...

Digital health solutions specialist Adherium (ASX: ADR) is celebrating news that global biopharmaceutical giant AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial. Under the contract, valued at $1.1 million, Astr...

  To register for today's webinar click here. Adherium (ASX:ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that AstraZeneca has selected its Hailie® Smartinhaler® platform for a clini...

24 May 2024 - A snapshot of the stocks on the move, featuring Adherium (ASX:ADR), Nanoveu (ASX:NVU) and Nimy Resources (ASX:NIM).

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

S&P/ASX 200 fell 2.94% in April as all Australian equity indexes fell except Emerging Companies Utilities and Materials the only ASX sectors in positive territory for April, up 4.77% and 0.61% respectively Rincon Resources  tops the wi...

Asthma affects hundreds of millions of people globally While inhalers are effective, people are not taking them correctly Adherium addresses this problem, as we reached out to CEO Paul Mastoridis   It’s one of the most common chronic dise...

The ASX slumped by over -1pc, as jitters about delayed rate cuts rattled markets Miner BHP confirmed  $60 billion bid for competitor Anglo American Gold stocks climbed, but all 11 sectors closed in the red   The ASX 200 declined sharply b...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

This week’s Bulls N’ Bears top ASX runner is … Dalaroo Metals. Its share price rose more than 182 per cent to join Nimy Resources, Adherium and Firebrick Pharma.

Medical device developer Adherium (ASX: ADR) has been given clearance by the US Food and Drug Administration (FDA) for its Hailie Smartinhaler to be used with AstraZeneca’s Airsupra and Breztri inhalation devices. Airsupra is the first FDA-...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Local markets end hopelessly, slightly lower IT sector surges 2.9%   Small Caps led by incredible Nyrada outperformance   Despite a return to form for lithium and a stunning 420% rally for little local drugmaker Nyrada, the ASX200 was t...

  Local markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for Energy Small Caps led by Enova Mining   Australian sharemarkets lacked all the vim, vigour and vinegar one associates with victory on Mond...

Adherium (ASX:ADR) says it will be exhibiting and meeting with commercial partners at the American Academy of Allergy, Asthma and Immunology’s 2024 Annual Meeting in Washington.

  Local markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat   The ASX200 has ended a second slumbrous session slightly lower, with a little dribble in the shape of the Star Casino at the corner of its mouth. US M...

The ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the green, IT ahead by circa +2pc Small caps led by Euro Manganese The local market has trimmed the CPI fat of this morning’s gains, after the...

The ASX benchmark has ended Tuesday higher 8 of 11 sectors in the green Small caps led by Plenti Group (ASX:PLT), InteliCare (ASX:ICR) The local market has trimmed some of its early gains (wussed out) after jumping out of the blocks in...

The ASX benchmark has closed higher on Tuesday Materials sector leads gains, up +1.44% Small caps led by ROO, CBE   The Aussie sharemarket has made it two on the trot, ending the Tuesday session slightly higher, as markets across the Asi...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

The ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose over the weekend Small caps led Killi Resources, Nyrada and Viridis Mining   The Aussie sharemarket has ended the opening salvo of the week...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

ASX200 closes +1.13% higher Property stocks, Industrials and IT Sector gain more than 2% Small caps led by takeover target MCM   The Australian sharemarket has ended the first week of November with another stout performance, momentarily a...

Benchmark ASX closes below 6,800 points  All Sectors in red, but for IT Small caps led, in a very big way, by TG6    The benchmark has ended sharply lower after weak overseas leads, strong retail data and an all-round international-flavou...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Adherium (ASX:ADR) has commenced production and market release of its new Hailie sensors with physiological parameters connecting GSK product inhalers for monitoring Asthma and Chronic Obstructive Pulmonary Disease.

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead’s Top 10 at shortly-before-11-ish, surprisingly close to on time this morning considering there’s an electrician’s apprentice hovering around my desk instead of testing the smoke alarms in my home like he’s meant to be doing. His...

Australian digital health company Adherium (ASX:ADR) has announced a new partnership in which SENTA Partners has agreed to roll out the Hailie platform to its base of clinics and patients across their network.

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...